This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Jiangsu Hansoh Pharmaceutical Group Co., Ltd., Shanghai Hansoh Biomedical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Xiaofeng Mao in Pharmaceutical Modulation
Introduction
Xiaofeng Mao is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate G protein-coupled receptors. His work is essential for advancing treatments for central nervous system diseases and mental disorders.
Latest Patents
Xiaofeng Mao holds 1 patent for his invention titled "Modifier of four-membered ring derivative, preparation method and application thereof." This patent describes a compound represented by the general formula (IX-A), along with its preparation method and pharmaceutical applications. The compound is particularly useful as a modulator in the treatment or prevention of various central nervous system and mental diseases.
Career Highlights
Throughout his career, Xiaofeng Mao has worked with prominent companies in the pharmaceutical industry, including Shanghai Hansoh Biomedical Co., Ltd. and Jiangsu Hansoh Pharmaceutical Group Co., Ltd. His experience in these organizations has allowed him to contribute to significant advancements in drug development.
Collaborations
Xiaofeng has collaborated with several professionals in his field, including Yidong Su and Kailong Li. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Xiaofeng Mao's innovative contributions to pharmaceutical modulation demonstrate his commitment to improving healthcare solutions. His patent and collaborations reflect his significant role in advancing treatments for critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile